Methods of ovarian suppression used in the UK

Beatson, 1896, On the treatment of inoperable cases of carcinoma of the mamma – suggestions for a new method of treatment with illustrative cases, Lancet, 2, 104, 10.1016/S0140-6736(01)72307-0 Nissen-Meyer, 1991, Primary breast cancer: the effect of primary irradiation, Oncol, 2, 343 Kennedy, 1964, Therapeutic castration in the treatment of advanced breast cancer, Cancer, 17, 1197, 10.1002/1097-0142(196409)17:9<1197::AID-CNCR2820170916>3.0.CO;2-T Huggins, 1953, Adrenalectomy and oophorectomy in the treatment of advanced carcinoma of the breast, JAMA, 151, 1388 1996, Lancet, 339, 1 Boccardo, 1994, Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study, Ann Oncol, 5, 337, 10.1093/oxfordjournals.annonc.a058837 1996, Lancet, 348, 1189, 10.1016/S0140-6736(96)05023-4 Taylor, 1998, Multicentre randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic disease: an intergroup study, J Clin Oncol, 16, 994, 10.1200/JCO.1998.16.3.994 Clarke, 1998, Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review, BMJ, 317, 1246, 10.1136/bmj.317.7167.1246 1990, Ann Oncol, 1, 30, 10.1093/oxfordjournals.annonc.a057670 Richards, 1990, Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node positive breast cancer-an update of the Guy's/Manchester trial, J Clin Oncol, 8, 2032, 10.1200/JCO.1990.8.12.2032 Padmanabhan, 1987, Ovarian function and adjuvant chemotherapy for early breast cancer, Eur J Cancer Clin Oncol, 23, 745, 10.1016/0277-5379(87)90272-0 Bonadonna, 1977, The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance, Cancer, 39, 2904, 10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8 Jordan, 1987, Endocrine effects of adjuvant chemotherapy and long term Tamoxifen on node-positive patients with breast cancer, Cancer Res, 47, 624 Blackburn, 1984, Effect of prednisolone on hormone profiles during primary endocrine treatment of Advanced Breast Cancer, Cancer Treat Rep, 68, 1447 Adjuvant Breast Cancer Premenopausal Trial Protocol, UKCCCR Trials Office, Imperial Cancer Research Unit, Sutton, UK. Featherstone, 1999, Ultrasound localization of the ovaries for radiation-induced ovarian ablation, Clin Oncol, 11, 393, 10.1053/clon.1999.9090 Counsell, 1996, Artificial radiation menopause: where are the ovaries, Clin Oncol, 8, 250, 10.1016/S0936-6555(05)80664-8 Leung, 1991, Ovarian ablation failures by radiotherapy: a comparison of two dose schedules, Br J Radiol, 64, 537, 10.1259/0007-1285-64-762-537 Robertson, 1989, Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Novaldex) therapy in premenopausal women with breast cancer, Br J Surg, 76, 1262, 10.1002/bjs.1800761213 Kaufmann, 1998, Luteinizing hormone-releasing hormone analogues in early breast cancer: updated status of ongoing clinical trials, Br J Cancer, 78, 9, 10.1038/bjc.1998.755